Details for Patent: 7,511,014
✉ Email this page to a colleague
Summary for Patent: 7,511,014
Title: | Cyclosporin galenic forms |
Abstract: | Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10. |
Inventor(s): | Cavanak; Thomas (Biel-Benken, CH), Posanski; Ulrich (Freiburg, DE) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 11/453,504 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 7,511,014
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,511,014
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 8903804.6 | Feb 20, 1989 |
International Family Members for US Patent 7,511,014
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Belgium | 1005236 | ⤷ Try a Trial | |||
Switzerland | 680650 | ⤷ Try a Trial | |||
Cyprus | 1886 | ⤷ Try a Trial | |||
Germany | 4005190 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |